Artificial Intelligence and Antimicrobial Resistance: Innovation, Global Challenges and the Future of Healthcare
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 8220
Special Issue Editors
Interests: genetics; genomics; phylodynamics; bioinformatics; biostatistics; population genetics; one health
Special Issues, Collections and Topics in MDPI journals
Interests: epidemiology; statistics; public health; artificial intelligence; predictive modeling; infectious diseases; data analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The growing threat of antimicrobial resistance (AMR) has made finding innovative solutions in the field of antibiotics crucial. Traditional methods for identifying new antibiotic compounds often involve exhaustive trial-and-error processes that are slow and expensive. In contrast, artificial intelligence (AI) emerges as a powerful tool that can analyze large amounts of data, identify useful patterns and improve treatment protocols. AI thus promises to accelerate the discovery of new antibiotic compounds and personalize prescriptions to maximize therapeutic efficacy. In addition, AI-driven surveillance systems can detect emerging resistance trends and inform targeted interventions. This Special Issue aims to explore the potential of AI in combating antimicrobial resistance, with the goal of developing sustainable solutions to preserve antibiotic efficacy and ensure effective antimicrobial therapy in the treatment of infectious diseases.
The scope of this Special Issue includes the following topics:
- AI-driven approaches for accelerating antibiotic discovery: Exploring machine learning algorithms and data analytics techniques to identify novel antibiotic compounds with enhanced efficacy and reduced likelihood of resistance development;
- Personalized antibiotic therapy using AI: Investigating how AI algorithms can analyze patient data to tailor antibiotic prescriptions based on individual profiles, optimizing treatment outcomes while minimizing the risk of antimicrobial resistance;
- AI-powered surveillance systems for monitoring antimicrobial resistance: Examining the role of AI in real-time data analysis to detect emerging resistance trends, identify high-risk populations and guide targeted interventions for containment;
- AI-driven strategies for optimizing antibiotic stewardship programs: Assessing the effectiveness of AI-driven decision support systems in promoting judicious antibiotic use, reducing unnecessary prescriptions and mitigating the spread of resistant pathogens;
- Interdisciplinary approaches to combatting antimicrobial resistance: Encouraging collaborations between AI researchers, microbiologists, pharmacologists and healthcare professionals to develop holistic solutions for addressing the complex challenges posed by antimicrobial resistance;
- Future directions in AI research for antimicrobial resistance: Proposing novel methodologies, technologies and research priorities to advance the field of AI-driven antimicrobial resistance research and accelerate progress toward sustainable solutions for preserving antibiotic efficacy.
Dr. Fabio Scarpa
Dr. Francesco Branda
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- artificial intelligence
- digital health
- drug discovery
- patient-centric care
- therapeutic innovations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
